Recovery Is Not Passive: Why Regulatory T Cells Reveal the Energetic Cost of Healing

When we think about the immune system, we usually picture its defensive side: detecting danger, attacking pathogens, and generating inflammation. But an effective immune response is not complete when the threat is contained. The body must also stop the response, clear the damage, rebuild tissue, and restore tolerance.

That final stage is recovery—and recovery requires work.

A major 2026 review by Jeffrey Bluestone and colleagues places regulatory T cells, or Tregs, at the center of this process. Rather than describing Tregs as simple “brakes” on immunity, the authors portray them as highly adaptive coordinators of immune tolerance, tissue repair, metabolic regulation, and long-term homeostasis.

This view fits closely with the Respond–Adapt–Recover framework. Effector immune cells dominate the initial response. Metabolic and physiological systems then reorganize to sustain adaptation. Tregs help orchestrate the difficult transition from sustained adaptation back toward resolution, repair, and flexible regulation.

The important implication is that recovery does not happen automatically. It must be actively produced—and that production has a bioenergetic cost.

The immune response is only the beginning

During the respond phase, the body mobilizes energy rapidly.

Immune cells proliferate. Cytokines are produced. Blood flow and nutrient allocation change. The liver redirects protein synthesis toward acute-phase defense. Glucose and fatty acids are mobilized. Mitochondria and glycolytic pathways are reprogrammed to support immune activation.

These changes are protective. They help the body contain infection, injury, toxins, or other threats.

But they are not designed to continue indefinitely.

If the stressor persists, or if the body cannot restore balance, the system enters a prolonged adapt phase. Energy remains preferentially allocated to defense, vigilance, inflammation, and short-term survival. Growth, maintenance, repair, and regulatory reset may become relatively under-supported.

The transition into recovery therefore requires more than simply removing the original trigger. The immune system must be actively reorganized from a defensive state into a reparative and tolerogenic one.

This is where Tregs become particularly important.

Tregs do more than suppress inflammation

Tregs are often introduced as immune cells that prevent autoimmunity. That description is correct, but incomplete.

The review describes Tregs as “master orchestrators” because they use multiple overlapping mechanisms to reshape the immune environment. They release anti-inflammatory mediators such as IL-10 and TGF-β, restrain antigen-presenting cells through CTLA-4 and related pathways, consume IL-2, generate anti-inflammatory adenosine, and influence the metabolic conditions surrounding other immune cells.

These mechanisms do not merely shut down immune activity. They help determine where inflammation occurs, how long it lasts, and whether it resolves without causing unnecessary tissue damage.

Tregs can also create a local “field” of tolerance. A Treg directed toward one antigen may suppress nearby immune responses against other antigens through bystander suppression. Tregs can also promote the development of additional regulatory cells, allowing tolerance to persist through a process known as infectious tolerance.

In other words, Tregs do not simply inhibit isolated immune cells. They help rebuild a regulatory network.

Tregs are also repair cells

One of the most important themes in the review is that Tregs are active participants in tissue repair.

Depending on the tissue, Tregs can communicate with macrophages, endothelial cells, fibroblasts, epithelial cells, stem cells, and progenitor cells. They can release amphiregulin and other growth-supporting factors that help restore damaged muscle, lung, skin, heart, and nervous tissue.

In the brain and spinal cord, Tregs can restrain inflammatory glial responses and support remyelination. In skeletal muscle, they help activate satellite cells involved in regeneration. In the skin, they contribute to wound healing and hair-follicle repair. In the lung, they support epithelial recovery after injury.

Some of these reparative actions are partly independent of classical immune suppression. A Treg may still suppress inflammation while losing its ability to promote tissue repair, or vice versa.

This distinction matters because successful recovery requires both:

resolution of inflammation + reconstruction of tissue

Suppressing inflammation without restoring damaged tissue is incomplete recovery. Repairing tissue without resolving inflammatory signaling is equally unstable.

Tregs help coordinate both sides.

Recovery has an energetic price

Every one of these functions requires energy.

Tregs must survive, migrate, proliferate, maintain FOXP3 expression, preserve epigenetic identity, synthesize cytokines and growth factors, communicate with other cells, remodel local metabolism, and remain functional inside damaged or inflamed tissues.

That requires:

• ATP production;

• mitochondrial respiration;

• redox control;

• protein synthesis;

• membrane trafficking;

• cytoskeletal movement;

• nutrient sensing;

• lipid and amino-acid metabolism;

• epigenetic maintenance.

Recovery is therefore not the absence of immune activity. It is a different form of biological activity—one directed toward resolution, repair, and restoration.

Within the Respond–Adapt–Recover framework:

Respond=energy mobilization for defense

Adapt=energy reallocation to sustain function under stress

Recover=energy investment in resolution, repair, and regulatory reset

This helps explain why someone may survive an acute stressor but recover slowly. The body may have generated enough energy to mount a response and maintain adaptation, yet lack sufficient reserve to complete the more prolonged work of repair and regulatory restoration.

Why Treg numbers alone may be misleading

A person can have Tregs present in the blood and still fail to recover effectively.

Function depends not only on the number of Tregs, but also on their:

• metabolic fitness;

• tissue-homing capacity;

• mitochondrial function;

• lineage stability;

• access to IL-2 and other supportive signals;

• ability to communicate with local stromal and immune cells;

• resistance to inflammatory conversion.

The review notes that chronic inflammatory cytokines can destabilize Treg identity. Under some conditions, Tregs may lose part of their regulatory program and acquire effector-like characteristics.

Aging adds another layer. Tregs may accumulate in certain tissues while becoming less effective. The review describes age-related metabolic drift, including a shift away from oxidative metabolism, along with impaired tissue communication and reduced regenerative function.

This is a crucial distinction:

More Tregs do not necessarily mean greater recovery capacity.

A metabolically impaired Treg may be present but unable to sustain the work required for tolerance and repair.

The review also highlights that stromal cells can transfer mitochondria to Tregs, improving their function under metabolic stress. This observation is particularly important because it shows that immune regulation depends on the energetic support of the surrounding tissue environment.

Tregs are not isolated actors. They function within a metabolic and cellular network.

Unresolved impedance may trap the system in adaptation

This connects directly with the concept of bioenergetic impedance.

When mitochondrial throughput is constrained, NAD⁺ availability is low, redox pressure remains elevated, or nutrient and oxygen delivery are inadequate, the body may struggle to complete the work of recovery.

The sequence may then become:

persistent bioenergetic constraint

→impaired Treg function

→incomplete inflammatory resolution

→delayed tissue repair

→further metabolic and inflammatory burden

This creates a self-reinforcing loop.

Inflammation increases energetic demand. At the same time, inflammation can damage mitochondria, alter metabolism, disrupt stromal support, and destabilize the regulatory cells needed to terminate the response.

The system therefore remains caught between defense and recovery.

It is no longer in an acute response, but it has not returned to baseline. It has stabilized into unresolved adaptation.

Recovery requires a permissive environment

Treg-based therapy is often discussed as a way to increase or engineer regulatory cells.

But the review also suggests that the surrounding environment will determine whether these cells succeed.

A Treg entering a tissue still needs:

• adequate metabolic substrates;

• supportive cytokine signals;

• sufficient mitochondrial function;

• compatible stromal communication;

• appropriate redox balance;

• access to the injured site;

• an inflammatory burden that is not overwhelming.

This means that effective recovery may require more than stimulating Tregs. It may also require restoring the conditions in which Tregs can function.

The same principle applies beyond immune-cell therapy. A person recovering from infection, surgery, psychological stress, toxicant exposure, metabolic overload, or chronic inflammation needs enough energetic reserve to resolve the stress response, rebuild tissue, and restore regulatory flexibility.

Rest alone may not be sufficient when the biological capacity for recovery is impaired.

A new way to understand chronic disease

Many chronic conditions may involve not only excessive response, but failed recovery.

The original stressor may no longer be dominant. What persists is the metabolic, inflammatory, vascular, neuroendocrine, and immune architecture of adaptation.

From this perspective, chronic inflammation is not simply an immune system that remains “switched on.” It may be a system that lacks the energetic and regulatory capacity to complete the transition back to homeostasis.

Tregs provide a clear cellular example of this principle. They must perform active regulatory and reparative work. When they are metabolically supported, they help restore tolerance and tissue integrity. When they are destabilized or energetically constrained, inflammation and tissue damage may continue.

Response mobilizes. Adaptation sustains. Recovery rebuilds.

The review by Bluestone and colleagues broadens our understanding of Tregs from suppressor cells to architects of tolerance and repair.

Within the Respond–Adapt–Recover framework, they may be understood as central coordinators of the recovery phase. They help terminate residual immune activation, propagate regulatory networks, support tissue regeneration, and restore a stable but flexible baseline.

Their biology also reveals something more fundamental:

Recovery is not a passive return to normal. It is an active, coordinated, and energetically costly biological achievement.

Response mobilizes energy.

Adaptation reallocates energy.

Recovery invests energy to rebuild tolerance, repair tissue, and restore flexibility.

When that investment can be completed, resilience increases. When energetic impedance remains unresolved, adaptation may persist—and recovery may remain out of reach.

Bluestone, J. A., Levings, M. K., Ramsdell, F. J., Rudensky, A. Y., Tang, Q., & Trzonkowski, P. (2026). Regulatory T cells: Master orchestrators of immune tolerance and tissue homeostasis. Frontiers in Science, 4, Article 1792210. https://doi.org/10.3389/fsci.2026.1792210